PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 103 filers reported holding PASSAGE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $31,809,000 | -36.2% | 5,009,219 | 0.0% | 2.45% | -38.7% |
Q3 2021 | $49,892,000 | -24.8% | 5,009,219 | 0.0% | 3.99% | -34.7% |
Q2 2021 | $66,322,000 | -24.3% | 5,009,219 | 0.0% | 6.12% | -12.9% |
Q1 2021 | $87,561,000 | -31.6% | 5,009,219 | 0.0% | 7.02% | -28.8% |
Q4 2020 | $128,086,000 | +95.0% | 5,009,219 | 0.0% | 9.86% | +67.3% |
Q3 2020 | $65,671,000 | -52.0% | 5,009,219 | 0.0% | 5.90% | -51.0% |
Q2 2020 | $136,902,000 | +73.5% | 5,009,219 | 0.0% | 12.02% | +34.4% |
Q1 2020 | $78,895,000 | – | 5,009,219 | – | 8.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |